MRPL58 and breast cancer: Interestingly, the amounts of ICT1 correlate negatively with miR-1301-3p in breast cancer cells (Peng et al., 2018), miR-134 in hepatocarcinoma cells (Chang et al., 2017), and miR-205 in stomach cancer (Tao et al., 2017).